PerkinElmer Inc
NYSE:PKI
Intrinsic Value
PerkinElmer, Inc. engages in the provision of products, services, and solutions for diagnostics, food, environmental, life sciences, and applied markets. [ Read More ]
The intrinsic value of one PKI stock under the Base Case scenario is 30.26 USD. Compared to the current market price of 114.21 USD, PerkinElmer Inc is Overvalued by 74%.
Valuation Backtest
PerkinElmer Inc
Run backtest to discover the historical profit from buying and selling PKI stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
PerkinElmer Inc
Current Assets | 3.3B |
Cash & Short-Term Investments | 454.4m |
Receivables | 612.8m |
Other Current Assets | 2.2B |
Non-Current Assets | 10.8B |
PP&E | 671.3m |
Intangibles | 9.9B |
Other Non-Current Assets | 311.1m |
Current Liabilities | 1.5B |
Accounts Payable | 272.8m |
Accrued Liabilities | 527.9m |
Other Current Liabilities | 743.8m |
Non-Current Liabilities | 5.2B |
Long-Term Debt | 3.9B |
Other Non-Current Liabilities | 1.3B |
Earnings Waterfall
PerkinElmer Inc
Revenue
|
4.6B
USD
|
Cost of Revenue
|
-1.9B
USD
|
Gross Profit
|
2.7B
USD
|
Operating Expenses
|
-1.6B
USD
|
Operating Income
|
1.1B
USD
|
Other Expenses
|
-325.1m
USD
|
Net Income
|
746.1m
USD
|
Free Cash Flow Analysis
PerkinElmer Inc
PKI Profitability Score
Profitability Due Diligence
PerkinElmer Inc's profitability score is 56/100. The higher the profitability score, the more profitable the company is.
Score
PerkinElmer Inc's profitability score is 56/100. The higher the profitability score, the more profitable the company is.
PKI Solvency Score
Solvency Due Diligence
PerkinElmer Inc's solvency score is 54/100. The higher the solvency score, the more solvent the company is.
Score
PerkinElmer Inc's solvency score is 54/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
PKI Price Targets Summary
PerkinElmer Inc
Ownership
PKI Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
PKI Price
PerkinElmer Inc
Average Annual Return | 28.39% |
Standard Deviation of Annual Returns | 21.45% |
Max Drawdown | -43% |
Market Capitalization | 14.4B USD |
Shares Outstanding | 125 441 000 |
Percentage of Shares Shorted | 3.57% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
PerkinElmer, Inc. engages in the provision of products, services, and solutions for diagnostics, food, environmental, life sciences, and applied markets. The company is headquartered in Waltham, Massachusetts and currently employs 16,700 full-time employees. The firm operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment provides products and services targeted towards the life sciences and applied markets. The Diagnostics segment develops diagnostics, tools and applications focused on clinically oriented customers, especially within the reproductive health, immunodiagnostics and applied genomics markets. The firm provides early detection for genetic disorders from pregnancy to early childhood, and infectious disease testing for the diagnostics market. The company offers its products under various brand names, including AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific, BoBs, chemagic, Chitas, Datalytix, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROline, EUROPattern, FragilEase, Genoglyphix, GSP, and others.
Contact
IPO
Employees
Officers
The intrinsic value of one PKI stock under the Base Case scenario is 30.26 USD.
Compared to the current market price of 114.21 USD, PerkinElmer Inc is Overvalued by 74%.